• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Harvard University

These ‘smart’ bandages could heal chronic wounds

February 18, 2020 By Sean Whooley

UConn biomedical engineers are touting a wirelessly controlled “smart” bandage and corresponding platform for delivering medications to chronic, non-healing wounds. UConn’s School of Dental Medicine, School of Medicine and School of Engineering comprise the biomedical engineering department, which contributed to developing the smart bandage. Ali Tamayol, an associate professor at UConn, led the development of […]

Filed Under: Drug-Device Combinations, Featured, Wound Care Tagged With: digital health, Harvard University, mobile health, UConn School of Medicine, universityofnebraska

Researchers deliver cardiac stem cell therapy in preclinical trial using refillable patch

June 11, 2018 By Sarah Faulkner

Researchers have developed a small device designed to halt the effects of a heart attack by delivering a stem cell therapy directly to damaged cardiac tissue. In a study published in Nature Biomedical Engineering, researchers from Harvard University, the Massachusetts Institute of Technology, the National University of Ireland Galway and Trinity College Dublin reported that the […]

Filed Under: Cardiovascular, Drug-Device Combinations, Featured, Pharmaceuticals, Preclinical Trials, Research & Development Tagged With: Harvard University, Massachusetts Institute of Technology

Novartis, Harvard team up to develop immunotherapy drug-delivery systems

March 21, 2018 By Sarah Faulkner

Novartis

Novartis (NYSE:NVS), Harvard University and the Dana-Farber Cancer Institute are teaming up to develop the next generation of implantable and injectable biomaterials designed to delivery immunotherapies, the group reported today. Researchers from Harvard’s Wyss Institute for Biologically Inspired Engineering have worked for years to create systems that provide targeted, sustained delivery of immuno-oncology products. Now, Novartis […]

Filed Under: Drug-Device Combinations, Featured, Immunotherapy, Implants, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: Harvard University, Novartis, Wyss Institute

Researchers combine a smart phone, insulin pump and CGM in diabetes study

October 17, 2017 By Sarah Faulkner

diabetes

In a study published this week in Diabetes Care, researchers combined an insulin pump, a continuous glucose monitoring receiver and a smart phone with cloud-based algorithms to automatically monitor and adjust a patient’s glucose levels. The team pointed towards a number of systems that are designed to function as an artificial pancreas, but still require that […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Harvard University

Smart bandage releases medication as needed

October 10, 2017 By Sarah Faulkner

Smart bandage

A team of researchers from the University of Nebraska, Harvard Medical School and MIT have created a smart bandage that can be loaded with antibiotics, painkillers or other drugs and triggered by a smartphone. The bandage, made of electrically conductive fibers individually coated in a drug-loaded hydrogel, could be used to deliver multiple drugs at […]

Filed Under: Drug-Device Combinations, Featured, Regenerative Medicine, Research & Development, Wound Care Tagged With: Harvard University, Massachusetts Institute of Technology, universityofnebraska

X-Biotix to address antibiotic resistance with chemical scaffolds

May 30, 2017 By Sarah Faulkner

X-Chem Pharmaceuticals

X-Biotix Therapeutics launched today with technology from Harvard Medical School that the company said will aim to address the threat of antibiotic resistance. According to the multi-year collaboration and license agreement, the team plans to identify antibiotic scaffolds that target multi-drug-resistant Gram-negative pathogens. X-Biotix spun out of the privately-held biotech X-Chem, which develops novel small molecule therapeutics […]

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: Harvard University, xbiotixtherapeutics

Medicaid expansion tied to increase in prescriptions for diabetes drugs, birth control

April 20, 2017 By Sarah Faulkner

Prescription drugs

The number of prescriptions filled by adults using Medicaid rose 19% in states that expanded Medicaid compared to states that did not under the Affordable Care Act, according to a new study from the Harvard T.H. Chan School of Public Health. The largest increases were for drugs that help patients deal with chronic conditions, including […]

Filed Under: Diabetes, Featured, Pharmaceuticals, Policy Tagged With: Capitol Hill, Harvard University

Study: Laser-activated gold microstructures deliver cargo directly into cells

March 24, 2017 By Sarah Faulkner

Study: Laser-activated gold microstructures deliver cargo directly into cells

Researchers from the Harvard University’s John A. Paulson School of Engineering and Applied Sciences have developed a method to deliver molecules into cells using gold microstructures. The team published their work in ACS Nano. Previous work has been done to deliver drugs or DNA into cells by tricking or forcing open the cell membrane, but the […]

Filed Under: Featured, Oncology, Research & Development Tagged With: Harvard University

Evotec, Celgene ink drug development deal for stem cell treatments for neurodegenerative diseases

December 16, 2016 By Sarah Faulkner

Evotec, Celgene ink drug development deal for stem cell treatements for neurodegenerative diseases

Evotec (ETR:EVT) said today that it inked a 5-year drug discovery and development deal with Celgene (NSDQ:CELG) to identify stem cell therapies for a range of neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease. According to the agreement, Hamburg, Germany-based Evotec will receive an upfront payment of $45 million and Celgene will hold exclusive […]

Filed Under: Discovery, Distribution, Featured, Neurological, Stem Cells, Wall Street Beat Tagged With: Celgene, Evotec, Harvard University

Topical immunotherapy combo effective against early skin cancer

November 22, 2016 By Sarah Faulkner

Calcipotriol, 5-fluorouracil-1x1

Researchers from the Washington University School of Medicine and Harvard Medical School have shown that a combination of 2 topical drugs can trigger an immune response against precancerous skin lesions. The study was published yesterday in The Journal of Clinical Investigation. The 2 drugs, calcipotriol and 5-fluorouracil, have been in use for years – topical 5-fluorouracil is […]

Filed Under: Featured, Immunotherapy, Oncology, Pharmaceuticals, Research & Development Tagged With: Harvard University, Washington University School of Medicine

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS